DeCoteau JF - Search Results

1

Torlakovic EE, Slipicevic A, Flørenes VA, Chibbar R, DeCoteau JF, Bilalovic N. Torlakovic EE, et al. Among authors: decoteau jf. Histol Histopathol. 2008 Nov;23(11):1309-14. doi: 10.14670/HH-23.1309. Histol Histopathol. 2008. PMID: 18785112

2

Pax-5 expression in nonhematopoietic tissues.

Torlakovic E, Slipicevic A, Robinson C, DeCoteau JF, Alfsen GC, Vyberg M, Chibbar R, Flørenes VA. Torlakovic E, et al. Among authors: decoteau jf. Am J Clin Pathol. 2006 Nov;126(5):798-804. doi: 10.1309/XEC7-JMW9-YRM7-4RNO. Am J Clin Pathol. 2006. PMID: 17050077

3

RIZ1 is potential CML tumor suppressor that is down-regulated during disease progression.

Lakshmikuttyamma A, Takahashi N, Pastural E, Torlakovic E, Amin HM, Garcia-Manero G, Voralia M, Czader M, DeCoteau JF, Geyer CR. Lakshmikuttyamma A, et al. Among authors: decoteau jf. J Hematol Oncol. 2009 Jul 14;2:28. doi: 10.1186/1756-8722-2-28. J Hematol Oncol. 2009. PMID: 19602237 Free PMC article.

4

In human leukemia cells ephrin-B-induced invasive activity is supported by Lck and is associated with reassembling of lipid raft signaling complexes.

Jiang G, Freywald T, Webster J, Kozan D, Geyer R, DeCoteau J, Narendran A, Freywald A. Jiang G, et al. Mol Cancer Res. 2008 Feb;6(2):291-305. doi: 10.1158/1541-7786.MCR-07-0047. Mol Cancer Res. 2008. PMID: 18314490

5

N-myristoyltransferase: a potential novel diagnostic marker for colon cancer.

Shrivastav A, Varma S, Saxena A, DeCoteau J, Sharma RK. Shrivastav A, et al. J Transl Med. 2007 Nov 16;5:58. doi: 10.1186/1479-5876-5-58. J Transl Med. 2007. PMID: 18021392 Free PMC article.

6

MSH2-deficient murine lymphomas harbor insertion/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency microsatellite instability.

Lowsky R, Magliocco A, Ichinohasama R, Reitmair A, Scott S, Henry M, Kadin ME, DeCoteau JF. Lowsky R, et al. Among authors: decoteau jf. Blood. 2000 Mar 1;95(5):1767-72. Blood. 2000. PMID: 10688836 Free article.

7

Allosteric lariat peptide inhibitors of Abl kinase.

Bharathikumar VM, Barreto K, Decoteau JF, Geyer CR. Bharathikumar VM, et al. Among authors: decoteau jf. Chembiochem. 2013 Nov 4;14(16):2119-25. doi: 10.1002/cbic.201300253. Epub 2013 Sep 12. Chembiochem. 2013. PMID: 24030821

8

Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation.

Scott S, Kimura T, Ichinohasama R, Bergen S, Magliocco A, Reimer C, Kerviche A, Sheridan D, DeCoteau JF. Scott S, et al. Among authors: decoteau jf. Leuk Res. 2003 Jan;27(1):23-34. doi: 10.1016/s0145-2126(02)00078-4. Leuk Res. 2003. PMID: 12479849

9

Three-color flow cytometry in the diagnosis of malignant lymphoma based on the comparative cell morphology of lymphoma cells and reactive lymphocytes.

Ichinohasama R, DeCoteau JF, Myers J, Kadin ME, Sawai T, Ooya K. Ichinohasama R, et al. Among authors: decoteau jf. Leukemia. 1997 Nov;11(11):1891-903. doi: 10.1038/sj.leu.2400802. Leukemia. 1997. PMID: 9369423

10

RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia cell lines.

Pastural E, Takahashi N, Dong WF, Bainbridge M, Hull A, Pearson D, Huang S, Lowsky R, DeCoteau JF, Geyer CR. Pastural E, et al. Among authors: decoteau jf. Oncogene. 2007 Mar 8;26(11):1586-94. doi: 10.1038/sj.onc.1209959. Epub 2006 Sep 4. Oncogene. 2007. PMID: 16953217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page